ScienceGate
Advanced Search
Author Search
Journal Finder
Blog
Sign in / Sign up
ScienceGate
Search
Author Search
Journal Finder
Blog
Sign in / Sign up
Abstract 1836: Erlotinib induces NF-kappa B dependence that promotes EGFR tyrosine kinase inhibitor resistance in lung adenocarcinoma
Mapping Intimacies
◽
10.1158/1538-7445.am2014-1836
◽
2014
◽
Author(s):
Collin M. Blakely
◽
Evangelos Pazarentzos
◽
Saurabh Asthana
◽
Victor Olivas
◽
Irena Tan
◽
...
Keyword(s):
Tyrosine Kinase
◽
Lung Adenocarcinoma
◽
Tyrosine Kinase Inhibitor
◽
Kinase Inhibitor
◽
Nf Kappa B
◽
Egfr Tyrosine Kinase Inhibitor
◽
Egfr Tyrosine Kinase
◽
Inhibitor Resistance
Download Full-text
Related Documents
Cited By
References
Epigenetic Reprogramming Driven By Metabolic Alterations As A Mechanism Of EGFR – Tyrosine Kinase Inhibitor Resistance In Human Lung Adenocarcinoma
The FASEB Journal
◽
10.1096/fasebj.2020.34.s1.00602
◽
2020
◽
Vol 34
(S1)
◽
pp. 1-1
Author(s):
Abhilash Venugopalan
◽
Khoa Nguyen
◽
Matthew Lynberg
◽
Tapan Maity
◽
Yue Qi
◽
...
Keyword(s):
Tyrosine Kinase
◽
Lung Adenocarcinoma
◽
Tyrosine Kinase Inhibitor
◽
Human Lung
◽
Kinase Inhibitor
◽
Egfr Tyrosine Kinase Inhibitor
◽
Metabolic Alterations
◽
Human Lung Adenocarcinoma
◽
Egfr Tyrosine Kinase
◽
Inhibitor Resistance
Download Full-text
EP1.14-46 The KIF5B-RET Fusion as a Novel Mechanism of Acquired EGFR Tyrosine Kinase Inhibitor Resistance in Lung Adenocarcinoma
Journal of Thoracic Oncology
◽
10.1016/j.jtho.2019.08.2331
◽
2019
◽
Vol 14
(10)
◽
pp. S1049
Author(s):
Y. Zhu
◽
W. Wang
◽
C. Xu
◽
Q. Zhang
◽
W. Zhuang
◽
...
Keyword(s):
Tyrosine Kinase
◽
Lung Adenocarcinoma
◽
Tyrosine Kinase Inhibitor
◽
Kinase Inhibitor
◽
Egfr Tyrosine Kinase Inhibitor
◽
Egfr Tyrosine Kinase
◽
Inhibitor Resistance
Download Full-text
The KIF5B-RET Fusion Gene Mutation as a Novel Mechanism of Acquired EGFR Tyrosine Kinase Inhibitor Resistance in Lung Adenocarcinoma
Clinical Lung Cancer
◽
10.1016/j.cllc.2018.09.011
◽
2019
◽
Vol 20
(1)
◽
pp. e73-e76
◽
Cited By ~ 3
Author(s):
You-cai Zhu
◽
Wen-xian Wang
◽
Qu-xia Zhang
◽
Chun-wei Xu
◽
Wu Zhuang
◽
...
Keyword(s):
Tyrosine Kinase
◽
Lung Adenocarcinoma
◽
Tyrosine Kinase Inhibitor
◽
Gene Mutation
◽
Kinase Inhibitor
◽
Fusion Gene
◽
Egfr Tyrosine Kinase Inhibitor
◽
Egfr Tyrosine Kinase
◽
Inhibitor Resistance
Download Full-text
Abstract 1756: Novel irreversible EGFR tyrosine kinase inhibitor, DBPR112, as a therapeutic candidate for lung adenocarcinoma
10.1158/1538-7445.am2014-1756
◽
2014
◽
Author(s):
Hui-Yi Shiao
◽
Tsu-An Hsu
◽
Wen-Hsing Lin
◽
Tsong-Toh Yang
◽
Hui-Fang Hsieh
◽
...
Keyword(s):
Tyrosine Kinase
◽
Lung Adenocarcinoma
◽
Tyrosine Kinase Inhibitor
◽
Kinase Inhibitor
◽
Egfr Tyrosine Kinase Inhibitor
◽
Egfr Tyrosine Kinase
Download Full-text
Different mutational characteristics of the subsets of EGFR-tyrosine kinase inhibitor sensitizing mutation-positive lung adenocarcinoma
BMC Cancer
◽
10.1186/s12885-018-5116-9
◽
2018
◽
Vol 18
(1)
◽
Cited By ~ 1
Author(s):
Eun Young Kim
◽
Arum Kim
◽
Gaeun Lee
◽
Hangsuck Lee
◽
Yoon Soo Chang
Keyword(s):
Tyrosine Kinase
◽
Lung Adenocarcinoma
◽
Tyrosine Kinase Inhibitor
◽
Kinase Inhibitor
◽
Egfr Tyrosine Kinase Inhibitor
◽
Egfr Tyrosine Kinase
Download Full-text
Programmed death-ligand 1 expression level as a predictor of EGFR tyrosine kinase inhibitor efficacy in lung adenocarcinoma
Translational Lung Cancer Research
◽
10.21037/tlcr-20-893
◽
2021
◽
Vol 10
(2)
◽
pp. 699-711
Author(s):
Minsu Kang
◽
Changhee Park
◽
Se Hyun Kim
◽
Sock Won Yoon
◽
Koung Jin Suh
◽
...
Keyword(s):
Tyrosine Kinase
◽
Lung Adenocarcinoma
◽
Tyrosine Kinase Inhibitor
◽
Kinase Inhibitor
◽
Expression Level
◽
Egfr Tyrosine Kinase Inhibitor
◽
Programmed Death Ligand 1
◽
Egfr Tyrosine Kinase
◽
Programmed Death
Download Full-text
The mechanism of acquired resistance to irreversible EGFR tyrosine kinase inhibitor-afatinib in lung adenocarcinoma patients
Oncotarget
◽
10.18632/oncotarget.7189
◽
2016
◽
Vol 7
(11)
◽
pp. 12404-12413
◽
Cited By ~ 115
Author(s):
Shang-Gin Wu
◽
Yi-Nan Liu
◽
Meng-Feng Tsai
◽
Yih-Leong Chang
◽
Chong-Jen Yu
◽
...
Keyword(s):
Tyrosine Kinase
◽
Lung Adenocarcinoma
◽
Tyrosine Kinase Inhibitor
◽
Kinase Inhibitor
◽
Acquired Resistance
◽
Egfr Tyrosine Kinase Inhibitor
◽
Egfr Tyrosine Kinase
Download Full-text
Predictive value of serum HGF for treatment response to EGFR tyrosine kinase inhibitor in patients with lung adenocarcinoma.
Journal of Clinical Oncology
◽
10.1200/jco.2010.28.15_suppl.7563
◽
2010
◽
Vol 28
(15_suppl)
◽
pp. 7563-7563
Author(s):
K. Kasahara
◽
T. Arao
◽
K. Sakai
◽
A. Sakai
◽
T. Sone
◽
...
Keyword(s):
Tyrosine Kinase
◽
Lung Adenocarcinoma
◽
Tyrosine Kinase Inhibitor
◽
Treatment Response
◽
Predictive Value
◽
Kinase Inhibitor
◽
Egfr Tyrosine Kinase Inhibitor
◽
Egfr Tyrosine Kinase
Download Full-text
Survival‑associated factors of first‑line EGFR‑tyrosine kinase inhibitor responders and non‑responders in lung adenocarcinoma patients with common EGFR mutations
Molecular and Clinical Oncology
◽
10.3892/mco.2018.1550
◽
2018
◽
Author(s):
Ming‑Szu Hung
◽
Yu‑Hung Fang
◽
Yu‑Ching Lin
◽
Jr‑Hau Lung
◽
Meng‑Jer Hsieh
◽
...
Keyword(s):
Tyrosine Kinase
◽
Lung Adenocarcinoma
◽
Tyrosine Kinase Inhibitor
◽
Associated Factors
◽
Kinase Inhibitor
◽
Egfr Mutations
◽
First Line
◽
Egfr Tyrosine Kinase Inhibitor
◽
Egfr Tyrosine Kinase
Download Full-text
Correlation between Efficacy of the EGFR Tyrosine Kinase Inhibitor and Serum Tumor Markers in Lung Adenocarcinoma Patients
Clinical Laboratory
◽
10.7754/clin.lab.2013.131002
◽
2014
◽
Vol 60
(09/2014)
◽
Cited By ~ 1
Author(s):
Jin Pan
◽
Yu Hou
◽
Guo Zhang
Keyword(s):
Tyrosine Kinase
◽
Lung Adenocarcinoma
◽
Tyrosine Kinase Inhibitor
◽
Tumor Markers
◽
Kinase Inhibitor
◽
Egfr Tyrosine Kinase Inhibitor
◽
Serum Tumor Markers
◽
Egfr Tyrosine Kinase
Download Full-text
Sign in / Sign up
Close
Export Citation Format
Close
Share Document
Close